• What should mental health providers know about coronavirus (COVID-19)?

• What can I consider with regard to continuing treatment for patients with serious mental illness in the context of the coronavirus (COVID-19) pandemic?

• I want to offer my SMI patients telemental health visits. What is different now because of COVID-19 in terms of regulation and rules?

• Is it possible to plan for continuation of clozapine during emergencies (such as coronavirus COVID-19 pandemic, infectious disease, hurricanes, tornadoes, earthquakes, rioting) that destroy infrastructure or limit travel, or other issues that prevent a patient from coming to a clinic or laboratory for necessary assessments or blood monitoring?

• Psychological Effects of Quarantine During the Coronavirus Outbreak: What Healthcare Providers Need to Know

• Caring for Patients’ Mental Well-Being During Coronavirus and Other Emerging Infectious Diseases: A Guide for Clinicians

• Taking Care of Patients During the Coronavirus Outbreak: A Guide for Psychiatrists

• Mental Health and Behavioral Guidelines for Preparedness and Response to Coronavirus and other Emerging Infectious Outbreaks

• What are clinical considerations for giving LAIs during the COVID-19 public health emergency?

• How can I help my patients prepare for telehealth visits?

• During the COVID-19 pandemic, can pharmacies dispense clozapine without an absolute neutrophil count (ANC) blood test result?

• Considerations for telepsychiatry service implementation in the era of COVID-19

• Practice Guidance for COVID-19

• COVID Coach Mobile App

• Coronavirus and Mental Health: Taking Care of Ourselves During Infectious Disease Outbreaks

• Working Remotely During COVID-19

• SAMHSA Resources and Information on Coronavirus (COVID-19)

• Do stay at home orders like those related to COVID-19 increase the risk of domestic violence against people with SMI?

• How do living situations for those with serious mental illness affect their physical and mental health during the COVID-19 pandemic?

• How can mental health clinicians help those with SMI to adhere to physical distancing guidelines during the COVID-19 Pandemic?

• What are some ways we can support employees and staff during the COVID-19 pandemic?

• How do telephone visits (without video) during COVID-19 work in terms of what services can be offered and billed?

• Telepsychiatry Toolkit

• 50-State Emergency Teletherapy Practice Rules Survey for Counselors, MFTs, Psychologists, and Clinical Social Workers

• For Providers and Community Leaders: Helping People Manage Stress Associated with the COVID-19 Virus Outbreak

• Sustaining the Well-being of Healthcare Personnel During Coronavirus and other Infectious Disease Outbreaks

• Leader’s Guide to Risk Communication in the Face of Coronavirus and other Emerging Public Health Threats

• Managing Fatigue During Times of Crisis: Guidance for Nurses, Managers, and Other Healthcare Workers

• Telepsychiatry and COVID-19

• Caring for health care workers during crisis: Creating a resilient organization

• Coping With Stress During Infectious Disease Outbreaks

• What trends in psychiatric symptom increases have been observed by frontline clinicians working with individuals who have SMI during the COVID-19 crisis, and how are they being addressed?

• What are some useful strategies for conducting supervision remotely during or after the COVID-19 pandemic?

• What are strategies to support resilience and prevent burnout among mental health staff during and after the COVID-19 pandemic?

• What are successful communication strategies for managers in community mental health organizations during and after COVID-19?

• How has the U.S. public sector behavioral health system been changing in response to the COVID-19 pandemic? What will the “new normal” look like for the treatment of SMI?

• What are ways of addressing grief or anxiety during the COVID-19 pandemic?

• What guidance is there regarding CPT codes for group therapy and delivery of services in group homes during COVID-19 “stay at home” orders?

• Older Clinicians and the Surge in Novel Coronavirus Disease 2019 (COVID-19)

• Helping Staff Manage Stress When Returning to Work: Tips for Supervisors of Disaster Responders

• Understanding and Addressing Sources of Anxiety Among Health Care Professionals During the COVID-19 Pandemic

• Supporting Clinicians During the COVID-19 Pandemic

• Telehealth Tips: Managing Suicidal Clients During the COVID-19 Pandemic

• Peer-Led Recommendations for Supporting Individuals Receiving Care in State Psychiatric Facilities during the COVID-19 Crisis

• WEBINAR: Wellness Routines For Uncertain Times

• WEBINAR: COVID-19 – How to Support Ourselves and Others Through Times of Fear and Isolation

• WEBINAR: How to Increase Our Resiliency to Isolation and Loneliness During the COVID-19 Crisis

• Double Jeopardy: COVID-19 and Behavioral Health Disparities for Black and Latino Communities in the U.S.

• Resilience

• How can I bill for telehealth services related to the COVID-19 pandemic?

• Stress Management During Quarantine for Mental Health Providers Serving Latino Clients

• Tools for Behavioral Health Professionals During a Public Health Crisis

• WEBINAR: Practicing Self-Compassion

• WEBINAR: Older Adults & Isolation During COVID-19

• COVID-19 Mental Health Resource Hub

• Disasters and People With Serious Mental Illness

• Addressing the COVID-19 Pandemic in Populations With Serious Mental Illness

• What are the ways in which COVID-19 is associated with mental disorders?

• Clozapine & LAI Virtual Forum – March 2021 (Video) – LAIs during COVID-19

• How to Talk About the COVID-19 Vaccines with Individuals Who Have Serious Mental Illness

• Reopening Your Mental Health Practice: A Checklist to Help You Prepare for In-Person Office Visits

• Training and Technical Assistance Related to COVID-19

• First Episode of Psychosis in Hispanic American Youth Challenges During a Pandemic

• Mental Health and the COVID-19 Pandemic

• Supporting the Mental Health Workforce During and After COVID-19

• Vigilance and Monitoring for Clozapine Toxicity During COVID-19 Infection and Recommendations for Management